BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24319651)

  • 1. The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons.
    Honda D; Ishigaki S; Iguchi Y; Fujioka Y; Udagawa T; Masuda A; Ohno K; Katsuno M; Sobue G
    FEBS Open Bio; 2013; 4():1-10. PubMed ID: 24319651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.
    Ito D; Suzuki N
    Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases.
    Ishigaki S; Riku Y; Fujioka Y; Endo K; Iwade N; Kawai K; Ishibashi M; Yokoi S; Katsuno M; Watanabe H; Mori K; Akagi A; Yokota O; Terada S; Kawakami I; Suzuki N; Warita H; Aoki M; Yoshida M; Sobue G
    Brain; 2020 Aug; 143(8):2398-2405. PubMed ID: 32770214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
    Baloh RH
    Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of RNA/DNA Binding Protein Dysfunction in Oligodendrocytes in the Pathogenesis of the Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration Spectrum Diseases.
    Valori CF; Neumann M
    Front Neurosci; 2021; 15():724891. PubMed ID: 34539339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
    Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
    J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conjoint pathological cascades mediated by RNA-binding proteins, TDP-43, FUS and ataxin-2].
    Ito D
    Rinsho Shinkeigaku; 2012; 52(11):1221-3. PubMed ID: 23196570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).
    Lourenco GF; Janitz M; Huang Y; Halliday GM
    Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD.
    Fujioka Y; Ishigaki S; Masuda A; Iguchi Y; Udagawa T; Watanabe H; Katsuno M; Ohno K; Sobue G
    Sci Rep; 2013; 3():2388. PubMed ID: 23925123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
    Ratti A; Buratti E
    J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
    Neumann M
    Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different recognition modes of G-quadruplex RNA between two ALS/FTLD-linked proteins TDP-43 and FUS.
    Ishiguro A; Katayama A; Ishihama A
    FEBS Lett; 2021 Feb; 595(3):310-323. PubMed ID: 33269497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD.
    Shenouda M; Zhang AB; Weichert A; Robertson J
    Adv Neurobiol; 2018; 20():239-263. PubMed ID: 29916022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of amyotrophic lateral sclerosis.
    Liscic RM; Breljak D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):370-2. PubMed ID: 20655970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-binding proteins with prion-like domains in ALS and FTLD-U.
    Gitler AD; Shorter J
    Prion; 2011; 5(3):179-87. PubMed ID: 21847013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
    Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
    Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
    A Armstrong R
    Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotrophic effects of progranulin in vivo in reversing motor neuron defects caused by over or under expression of TDP-43 or FUS.
    Chitramuthu BP; Kay DG; Bateman A; Bennett HP
    PLoS One; 2017; 12(3):e0174784. PubMed ID: 28358904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of Functional Loss of FUS in FTLD/ALS.
    Ishigaki S; Sobue G
    Front Mol Biosci; 2018; 5():44. PubMed ID: 29774215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.